➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Harvard Business School
McKesson
Baxter
Dow

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Patent: 10,240,205

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,240,205
Title:Methods for assessing risk of developing a viral disease using a genetic test
Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject\'s disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
Inventor(s): Hatchwell; Eli (Winchester, GB), Eis; Peggy S. (Fitchburg, WI), Smith, III; Edward B. (New York, NY), Taoufik; Yassine (Paris, FR)
Assignee: Population Bio, Inc. (New York, NY) The Universite Paris-Sud (FR) The Assistance Publique--Hopitaux de Paris (APHP) (FR) The Institut National de la Sante et de la Recherche Medicale (INSERM) (FR) PML Screening, LLC (Newport Beach, CA)
Application Number:15/639,591
Patent Claims:see list of patent claims

Details for Patent 10,240,205

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23   Start Trial Population Bio, Inc. (New York, NY) The Universite Paris-Sud (FR) The Assistance Publique--Hopitaux de Paris (APHP) (FR) The Institut National de la Sante et de la Recherche Medicale (INSERM) (FR) PML Screening, LLC (Newport Beach, CA) 2037-02-03 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Colorcon
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.